China SXT Pharmaceuticals, Inc.

NasdaqCM:SXTC Stock Report

Market Cap: US$1.5m

China SXT Pharmaceuticals Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Albert Zhou

Chief executive officer

US$50.0k

Total compensation

CEO salary percentage100.0%
CEO tenure7.5yrs
CEO ownership0.1%
Management average tenureno data
Board average tenure3.2yrs

Recent management updates

Recent updates

China SXT Pharmaceuticals'(NASDAQ:SXTC) Share Price Is Down 12% Over The Past Year.

Feb 09
China SXT Pharmaceuticals'(NASDAQ:SXTC) Share Price Is Down 12% Over The Past Year.

CEO Compensation Analysis

How has Albert Zhou's remuneration changed compared to China SXT Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024US$50kUS$50k

-US$3m

Dec 31 2023n/an/a

-US$9m

Sep 30 2023n/an/a

-US$14m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023US$50kUS$50k

-US$6m

Dec 31 2022n/an/a

-US$5m

Sep 30 2022n/an/a

-US$4m

Jun 30 2022n/an/a

-US$5m

Mar 31 2022US$50kUS$50k

-US$6m

Dec 31 2021n/an/a

-US$6m

Sep 30 2021n/an/a

-US$7m

Jun 30 2021n/an/a

-US$5m

Mar 31 2021US$50kUS$50k

-US$3m

Dec 31 2020n/an/a

-US$5m

Sep 30 2020n/an/a

-US$7m

Jun 30 2020n/an/a

-US$8m

Mar 31 2020US$50kUS$50k

-US$10m

Dec 31 2019n/an/a

-US$6m

Sep 30 2019n/an/a

-US$2m

Jun 30 2019n/an/a

-US$132k

Mar 31 2019US$18kUS$18k

US$2m

Dec 31 2018n/an/a

US$1m

Sep 30 2018n/an/a

US$1m

Jun 30 2018n/an/a

US$1m

Mar 31 2018US$7kUS$7k

US$1m

Compensation vs Market: Albert's total compensation ($USD50.00K) is below average for companies of similar size in the US market ($USD645.26K).

Compensation vs Earnings: Albert's compensation has been consistent with company performance over the past year.

CEO

Albert Zhou (32 yo)

7.5yrs

Tenure

US$50,000

Compensation

Mr. Feng Zhou, also known as Albert, had been Interim Chief Financial Officer of China SXT Pharmaceuticals, Inc. since July 8, 2020 until February 1, 2021. Mr. Zhou has been Chief Executive Officer and Dir...

Board Members

NamePositionTenureCompensationOwnership
Feng Zhou
Chairman of the Board & CEOno dataUS$50.00k0.12%
$ 1.8k
Jun Zheng
Executive Director6yrsno datano data
Xiaodong Ji
Independent Director3.7yrsno datano data
Tong Liu
Independent Director2.7yrsno datano data
Songfan He
Independent Director2.7yrsno datano data

3.2yrs

Average Tenure

46yo

Average Age

Experienced Board: SXTC's board of directors are considered experienced (3.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 21:34
End of Day Share Price 2025/01/22 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China SXT Pharmaceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution